Assessing Clinical Outcomes of Metronidazole for Intra-Abdominal Infections When Dosed Every 12 h Versus Every 8 h in a Multi-Center Health System
<b>Background</b>: Metronidazole is the preferred anaerobic agent for empiric treatment of intra-abdominal infections (IAI). Although dosed every 8 h (q8hr), blood concentrations exceed the in vitro minimum inhibitory concentration (MIC) for anaerobic organisms at 12 h (q12hr). A drug sh...
Saved in:
Main Authors: | Sarah Galante, Ramya Castillo, Todd Price, MaiCuc Tran, Stefanie Stramel-Stafford |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/7/688 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spectrophotometric determination of Metronidazole and Metronidazole benzoate via first and Second Derivative order spectroscopy
by: Baghdad Science Journal
Published: (2017-06-01) -
INFLUENCE OF METRONIDAZOLE ON BIOLOGICAL ACTION OF DOXORUBICIN
by: S. A. Yagubov, et al.
Published: (2017-09-01) -
Rare Case of Metronidazole-Induced Encephalopathy in a Multiple Transplant Recipient: Clinical and Radiological Insights
by: Bisher Sawaf, et al.
Published: (2025-06-01) -
EFFECT OF SOLID DISPERSIONS ON THE SOLUBILITY OF METRONIDAZOLE
by: I. I. Krasnyuk (Jr.), et al.
Published: (2021-08-01) -
Theory and Practice of the Use of Metronidazole Topical Preparations in Dermatology
by: V. I. Kocherovets
Published: (2020-05-01)